Search Records

Currently, the treatment of COVID-19 includes supportive care and treatment of any secondary infections, such as pneumonia. There are no drugs or vaccines approved, but there are now 18 clinical trials authorized in Canada with diagnostic equipment, supportive care and/or treatments for COVID-19.

This list contains non-diagnostic devices of all classes - Classes I - IV - that are specifically authorized for use against COVID-19. These devices are authorized under the Interim order respecting the importation and sale of medical devices for use in relation to COVID-19. However, this list...

Presents a list of medical devices for use against COVID-19 applications submitted for authorization according to the Interim Order. This application list is updated daily Monday to Friday

Presents a list of medical devices for use against COVID-19 applications submitted for authorization according to the Interim Order. This application list is updated daily Monday to Friday

Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).

COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical...

To assist with Canada’s response to COVID-19, the Honourable Patty Hajdu, Minister of Health, announced that she has signed an Interim Order to allow expedited access to COVID-19-related medical devices for use by healthcare providers, including diagnostic test kits.

The Minister of Health, pursuant to subsection 30.1‍(1)Footnote(i) of the Food and Drugs Act Footnote(ii), makes the annexed Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.

Overview of the Health Portfolio, issues/priorities for the first 100 days and a pocket book with Health Portfolio highlights.

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the...